New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Ionis Pharmaceuticals has just released their findings from a study investigating the effect of IONIS-PKK-LRx and IONIS-PKKRx in hereditary angioedema (HAE) patients with different forms of the disease. These therapies work to reduce…

Continue Reading New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study
Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
source: pixabay.com

Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives

Over 2018 and 2019, BioCryst Pharmaceuticals conducted two surveys to better understand the needs and expectations of hereditary angioedema (HAE) patients. Overall, they found that despite progress in HAE therapies,…

Continue Reading Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
Arabel Spent Quarantine With her Mom and her Paints: An HAE Patient Story
source: pixabay.com

Arabel Spent Quarantine With her Mom and her Paints: An HAE Patient Story

Arabel Standingbear sketches figures with lead pencils and paints realistic scenes with acrylics. Her poem was accepted by a museum. She has won in local art contests between schools, and…

Continue Reading Arabel Spent Quarantine With her Mom and her Paints: An HAE Patient Story
May 16th is Hereditary Angioedema Day : Spreading Rare Disease Awareness
source: pixabay.com

May 16th is Hereditary Angioedema Day : Spreading Rare Disease Awareness

May 16th is celebrated annually as Hereditary Angioedema (HAE) Awareness Day. The event was established with the goal of spreading awareness about this rare condition among both the general public…

Continue Reading May 16th is Hereditary Angioedema Day : Spreading Rare Disease Awareness

RUCONEST Now Approved for Children with Hereditary Angioedema in Europe

The European Commission has just granted their approval to Pharming for an extended indication of RUCONEST (conestat alfa) for Hereditary Angioedema (HAE). This extension allows the therapy to be utilized for…

Continue Reading RUCONEST Now Approved for Children with Hereditary Angioedema in Europe
Berotralstat, to Treat Hereditary Angioedema, Under EMA Review
stevepb / Pixabay

Berotralstat, to Treat Hereditary Angioedema, Under EMA Review

According to Angioedema News, the European Medicines Agency (EMA) is now reviewing berotralstat as a potential therapy to combat severe inflammation attacks in patients with hereditary angioedema. Hereditary Angioedema Hereditary…

Continue Reading Berotralstat, to Treat Hereditary Angioedema, Under EMA Review
Study Assesses Rare Disease Treatments for Children From 2010-2018
source: pixabay.com

Study Assesses Rare Disease Treatments for Children From 2010-2018

According to a story from Charcot-Marie-Tooth News, a new study highlights the advances that have been made in the last decade for treating rare diseases that affect children. However, the…

Continue Reading Study Assesses Rare Disease Treatments for Children From 2010-2018
New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH
source: pixabay.com

New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH

Hereditary Angioedema Hereditary angioedema (HAE) is a rare disease which causes swelling episodes throughout the body, including the airways, gastrointestinal system, and extremities. Most commonly, HAE is caused by a…

Continue Reading New Study Examines Biomarkers of Hereditary Angioedema not Caused by C1-INH
New Tool can Measure Disease Activity in Hereditary Angioedema Type 1 and 2
source: pixabay.com

New Tool can Measure Disease Activity in Hereditary Angioedema Type 1 and 2

According to a story from Angioedema News, a team of researchers and scientists have successfully developed a tool that is able to measure disease activity in hereditary angioedema that is…

Continue Reading New Tool can Measure Disease Activity in Hereditary Angioedema Type 1 and 2

Study Reveals a More Efficient Approach for Diagnosing Certain Cases of Hereditary Angioedema

According to a story from Angioedema News, a recent study discusses a genetic procedure called allelic discrimination as a method for diagnosing hereditary angioedema. The study concluded that this method…

Continue Reading Study Reveals a More Efficient Approach for Diagnosing Certain Cases of Hereditary Angioedema
Study Links Age of Onset and Year of Birth to Delayed Diagnosis for Hereditary Angioedema
mohamed_hassan / Pixabay

Study Links Age of Onset and Year of Birth to Delayed Diagnosis for Hereditary Angioedema

According to a study recently published in Allergy and Asthma Proceedings, certain risk factors may increase an individual's likelihood of receiving a late diagnosis for hereditary angioedema. Hereditary angioedema is…

Continue Reading Study Links Age of Onset and Year of Birth to Delayed Diagnosis for Hereditary Angioedema
UK’s NICE Recommends Coverage for Hereditary Angioedema Drug Takhzyro
derwiki / Pixabay

UK’s NICE Recommends Coverage for Hereditary Angioedema Drug Takhzyro

According to a story from Angioedema News, the UK's National Institute for Health and Clinical Excellence (NICE) has officially recommended the drug lanadelumab (marketed as Takhzyro) for coverage under the…

Continue Reading UK’s NICE Recommends Coverage for Hereditary Angioedema Drug Takhzyro
Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks
qimono / Pixabay

Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks

According to a story from Angioedema News, a recent study demonstrated the effectiveness of the medication Haegarda in reducing the number of swelling attacks experienced by hereditary angioedema patients. Preventative…

Continue Reading Trial Demonstrates The Effectiveness of Haegarda in Treating Hereditary Angioedema Attacks
The Drug Firazyr is Safe for Older Hereditary Angioedema Patients, Study Finds
qimono / Pixabay

The Drug Firazyr is Safe for Older Hereditary Angioedema Patients, Study Finds

According to a story from Angioedema News, a recent study has found that the drug icatibant (marketed as Firazyr) can safely treat older patients with hereditary angioedema, a rare condition…

Continue Reading The Drug Firazyr is Safe for Older Hereditary Angioedema Patients, Study Finds
This Company is Making Plans to Develop a Gene Therapy for Hereditary Angioedema
skeeze / Pixabay

This Company is Making Plans to Develop a Gene Therapy for Hereditary Angioedema

According to a story from Angioedema News, the drug development company Regenxbio has announced that it is in the process of developing a new gene therapy treatment for hereditary angioedema,…

Continue Reading This Company is Making Plans to Develop a Gene Therapy for Hereditary Angioedema
Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows
cherylholt / Pixabay

Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows

According to a story from Angioedema News, a recent clinical trial has demonstrated that the drug conestat alfa (marketed as Ruconest) was able to successfully treat 96 percent of acute…

Continue Reading Hereditary Angioedema Drug Shows Safety and Efficacy in Pediatric Patients, Study Shows

Study Findings Result in New Diagnostic Recommendations for Hereditary Angioedema in the ER

According to a story from Angioedema News, a team of researchers has used data from a recent study to provide up to date recommendations for diagnosing hereditary angioedema in the…

Continue Reading Study Findings Result in New Diagnostic Recommendations for Hereditary Angioedema in the ER
Close Menu